Log in
Enquire now
‌

US Patent 11351269 Anti-NTB-A antibodies and related compositions and methods

Patent 11351269 was granted and assigned to Seagen on June, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Seagen
Seagen
Current Assignee
Seagen
Seagen
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
113512690
Patent Inventor Names
Django Sussman0
Timothy Lewis0
Lori Westendorf0
Che-Leung Law0
Date of Patent
June 7, 2022
0
Patent Application Number
157393630
Date Filed
June 30, 2016
0
Patent Primary Examiner
‌
Karen A. Canella
0
CPC Code
‌
C07K 2317/56
0
‌
C07K 16/2803
0
‌
C07K 2317/565
0
‌
A61P 35/00
0
‌
A61K 47/6851
0
‌
A61K 47/6803
0
‌
A61P 35/02
0
‌
C07K 2317/24
0

Disclosed are antibodies, including antibody drug conjugates, that specifically bind to NTB-A. Also disclosed are methods for using the anti-NTB-A antibodies to detect or modulate activity of (e.g., inhibit proliferation of) an NTB-A-expressing cell, as well as for diagnoses or treatment of diseases or disorders (e.g., cancer) associated with NTB-A-expressing cells, such as multiple myeloma, non-Hodgkin lymphoma and acute myeloid leukemia.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11351269 Anti-NTB-A antibodies and related compositions and methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.